This state of high expression also results in the apoptosis of CD8+ T cells, causing dysfunction of CD8+ T cells and promoting immune escape in HCC, thereby inhibiting the therapeutic efficacy of anti-PD-1 drugs. Here, CD8A is linked to hepatocellular carcinoma.